Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model

Chen, Chun, Ahn, Eun Hee, Kang, Seong Su, Liu, Xia, Alam, Ashfaqul, Ye, Keqiang·2020·Science Advances
DOI 10.1126/sciadv.aba0466

Cited by (206)

Items 201–206 of 206

  1. The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment
    Jingyi Wang, Lyu Luo, Jiawei Zhang, Lili Yu, Lili Cui · 2026 · Ageing Research Reviews
  2. Gut microbiota as a modulator of HDAC: insights into Alzheimer’s disease treatment
    Ekta Verma, Shweta Mishra, Hanish Singh Jayasingh Chellammal, Prasanna Shama Khandige, Amin Gasmi · 2026 · Pharmacological Reports
  3. Sleep and the Gut–Brain Axis: Bidirectional, Converging Mechanisms Linking Brain Health, Neuroinflammation, and Neurodegeneration
    Bryce Bowler, Abdul Rehman Nasir, Aldona Szewczyk, Sarah R. Ocañas, Archana Unnikrishnan, Claire Delpirou Nouh · 2026 · Pathophysiology
  4. Research Advances and Perspectives on Gut Microbiota Regulating Alzheimer’s Disease
    Fanfan Zhu, Xiaoyi Shao · 2026 · Biology
  5. DMS raw data_R21 DH
    Di Hu · 2024 · Zenodo (CERN European Organization for Nuclear Research)
  6. Microbiome-targeted strategies for Alzheimer’s disease: multi-omics signatures, mechanistic links, and intervention evidence
    Xuyang Huang, Xinyue Zhang, Zhu Qi · 2026 · Frontiers in Microbiology